Summary
In 8 healthy subjects the absorption of cimetidine was investigated when given alone, together with 60 ml aluminium/magnesium hyroxyde containing antacid (neutralising capacity 26 mmol HCl/10 ml), and together with liquid metoclopramide 14 mg. The antacid significantly (P<0.01) reduced the bioavailability (area under the plasma level-time curve) of cimetidine, on average by one third. Metoclopramide also reduced the bioavailability by an average of 22%. The reductions were associated with significantly reduced excretion of cimetidine in urine. There was no change in the half-life or renal clearance of cimetidine, supporting the hypothesis of reduced gastrointestinal absorption. The results indicate that cimetidine and antacids should not be given together, and that the dose of cimetidine may have to be increased if it is administered concomitantly with metoclopramide.
Similar content being viewed by others
References
Behar J, Brand DL, Brown FC, Castell DO, Cohen S, Crossley RJ, Pope II CE, Winans CS (1978) Cimetidine in the treatment of symptomatic gastroesophageal reflux. Gastroenterology 74: 441–448
Berkowitz DM, McCallum RW (1980) Interaction of levodopa and metoclopramide on gastric emptying. Clin Pharmacol Ther 27: 414–420
Bodemar G, Norlander B, Walan A (1979) Diminished absorption of cimetidine caused by antacid. Lancet 1: 444–445
Burland WL, Darkin DW, Mills MW (1976) Effect of antacids on absorption of cimetidine. Lancet 2: 965
Chiou WL (1978) Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J Pharmacokinet Biopharm 6: 539–546
Connell AM, George JD (1969) Effect of metoclopramide on gastric function in man. Gut 10: 678–680
Daniel WW (1978) The Friedman two-way analysis of variance by ranks. In: Applied nonparametric statistics, pp 223–231
Fordtran JS (1978) Placebos, antacids, and cimetidine for duodenal ulcer. N Engl J Med 298: 1081–1083
Fordtran JS, Morawski SG, Richardson CT (1973) In vivo and in vitro evaluation of liquid antacids. N Engl J Med 288: 923–928
Ganjian F, Cutie AJ, Jochsberger T (1980) In vitro adsorption studies of cimetidine. J Pharm Sci 69: 352–353
Gugler R, Fuchs G, Dieckmann M, Somogyi AA (1981) Plasma concentration response relationship for cimetidine. Clin Pharmacol Ther (in press)
Hurwitz A (1977) Antacid therapy and drug kinetics. Clin Pharmacokinet 2: 281–291
Hurwitz A, Robinson RG, Tribhawan SU, Whittier FC, Herrin WF (1976) Effects of antacids on gastric emptying. Gastroenterology 71: 268–273
Logan RFA, Forrest JAH, McLoughlin GP, Lidgard G, Heading RC (1978) Effect of cimetidine on serum gastrin and gastric emptying in man. Digestion 18: 220–226
Manninen V, Melin J, Apajalahti A, Karesoja M (1973) Altered absorption of digoxin in patients given propantheline and metoclopramide. Lancet 1: 398–399
Nimmo WS (1976) Drugs, diseases, and altered gastric emptying. Clin Pharmacokinet 1: 189–203
Randolph WC, Osborne VL, Walkenstein SS, Intoccia AP (1977) High-pressure liquid chromatographic analysis of cimetidine, a Histamine H2-receptor antagonist, in blood and urine. J Pharm Sci 66: 1148–1150
Somogyi A, Rohner HG, Gugler R (1980) Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Clin Pharmacokinet 5: 84–94
Steinberg WM, Lewis JH (1980) Mylanta II inhibits the absorption of cimetidine. Gastroenterology 78: 1269
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gugler, R., Brand, M. & Somogyi, A. Impaired cimetidine absorption due to antacids and metoclopramide. Eur J Clin Pharmacol 20, 225–228 (1981). https://doi.org/10.1007/BF00544602
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544602